Researchers at NYU Langone Medical Center and the Steven & Alexandra Cohen Veterans Center have developed new technology that can assess the location and impact of a brain injury merely by tracking the eye movements of patients as they watch music videos for less than four minutes, according to a study published in the Journal of Neurosurgery.
The study suggests that the use of eye tracking technology may be a potential biological marker for assessing brain function and monitoring recovery for patients with brain injuries. The study looked at 169 veterans; 157 of whom were neurologically healthy and 12 who either had known weaknesses in the nerves that move the eyes, or brain swelling adjacent to those nerves. These nerves affect how the eye moves up and down and side to side.
The investigators had the participants watch a music video or television content for 220 seconds while they measured the ratio of horizontal to vertical eye movements using new technology. They discovered that in the neurologically healthy subjects, the ratios were close to one-to-one, with horizontal movements equaling vertical movements. But the 12 participants with nerve damage or swelling in the brain pressing on nerves all showed abnormal eye movement ratios correlating to the nerve that was affected. In every case where the abnormal eye movement was due to swelling in the brain, surgery to fix the brain problem also restored the eye movements to normal range.
The team state that they are very excited about the findings because it offers a proof of concept that this technology can detect brain injury and suggest its location. One of the reasons that clinical trials for treatment of brain injury have failed in the past is that brain injury is hard to classify and quantitate with existing technologies. This invention suggests a potential new method for classifying and quantitating the extent of injury. The technology is not overly complicated and, as a result, can move from the bench to the battlefield and other places where it will be easily accessible to all. Once validated, it will both accelerate diagnosis and aid in the development of better treatments.
The team explain that because of its easy usability, it can be applied, for example, to study hundreds of subjects in a relatively short period of time. The researchers pointed in particular to recent eye-tracking study of over 600 active military at Fort Campbell in Kentucky, who were assessed with this technology in the first week after they returned home from their deployment. These studies will help further evaluate the technology’s effectiveness as a screening tool.
Brain injury is the number one cause of death and disability in Americans under age 35, According to the U.S. Centers for Disease Control and Prevention. Every year, 1.4 million people suffer from a traumatic brain injury in the United States. Of those, 50,000 die and 235,000 require hospital admission.
While the study concentrates on patients with brain abnormalities that are apparent on imaging, the team state that the technology will likely be most useful for the assessment of concussion and blast injury, which can be difficult to detect with standard imaging studies, and which is highly prevalent among returning veterans from the long Middle East wars. Because the eye-tracking assessment technology measures how well the brain functions rather than assesses what it looks like, it provides very different information than imaging studies.
It may also be helpful for triage. When a person falls and hits their head, it can be difficult to determine whether the injury is life-threatening. The eye-tracking assessment technology is potentially a simple, non-invasive and cost-effective way to determine quickly which patients need immediate attention.
Source: NYU Langone Medical Center
Michelle Petersen is the founder of Healthinnovations, having worked in the health and science industry for over 21 years, which includes tenure within the NHS and Oxford University. Healthinnovations is a publication that has reported on, influenced, and researched current and future innovations in health for the past decade.
Michelle has been picked up as an expert writer for Informa publisher’s Clinical Trials community, as well as being listed as a blog source by the world’s leading medical journals, including the acclaimed Nature-Springer journal series.
Healthinnovations is currently indexed by the trusted Altmetric and PlumX metrics systems, respectively, as a blog source for published research globally. Healthinnovations is also featured in the world-renowned BioPortfolio, BioPortfolio.com, the life science, pharmaceutical and healthcare portal.
Most recently the Texas A&M University covered The Top 10 Healthinnovations series on their site with distinguished Professor Stephen Maren calling the inclusion of himself and his team on the list a reflection of “the hard work and dedication of my students and trainees”.
Michelle Petersen’s copy was used in the highly successful marketing campaign for the mega-hit film ‘Jumanji: The Next Level, starring Jack Black, Karen Gilian, Kevin Hart and Dwayne ‘The Rock’ Johnson. Michelle Petersen’s copywriting was part of the film’s coverage by the Republic TV network. Republic TV is the most-watched English language TV channel in India since its inception in 2017.
An avid campaigner in the fight against child sex abuse and trafficking, Michelle is a passionate humanist striving for a better quality of life for all humans by helping to provide traction for new technologies and techniques within healthcare.